Abiopharma

New Form 4 - HCW Biologics Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068294 Size: 7 KB

New Form 4 - HCW Biologics Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068292 Size: 7 KB

New Form 4 - Kiniksa Pharmaceuticals International, plc Filed: 2025-05-09 AccNo: 0001415889-25-012571 Size: 20 KB

New Form 4 - HCW Biologics Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068287 Size: 7 KB

New Form SCHEDULE 13G/A - Allogene Therapeutics, Inc. Filed: 2025-05-09 AccNo: 0001415889-25-012568 Size: 38 KB

New Form 3 - iCoreConnect Inc. Filed: 2025-05-09 AccNo: 0001477932-25-003501 Size: 3 KB

New Form 4 - HCW Biologics Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068281 Size: 7 KB

New Form 3 - iCoreConnect Inc. Filed: 2025-05-09 AccNo: 0001477932-25-003503 Size: 3 KB

New Form 3 - iCoreConnect Inc. Filed: 2025-05-09 AccNo: 0001477932-25-003502 Size: 3 KB

New Form 4 - HCW Biologics Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068275 Size: 7 KB

Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K - TNF Pharmaceuticals, Inc. Filed: 2025-05-09 AccNo: 0001641172-25-009514 Size: 234 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 4 - HCW Biologics Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068271 Size: 7 KB

New Form 8-K - RECURSION PHARMACEUTICALS, INC. Filed: 2025-05-09 AccNo: 0001193125-25-116989 Size: 173 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Actinium Pharmaceuticals, Inc. Filed: 2025-05-09 AccNo: 0001213900-25-041614 Size: 4 MB